★★★★★ 5
Like the style
Color: Black-satin, Size: XX-Large
Fits good
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 4, 2026
tirzepatide in chinese Eli Lilly's Mounjaro added to China's state insurance list for diabetes treatment
Marsoni
M251S
Get it in 3 business days with 1 day shipping.
Friday, May 29
Zepbound (Tirzepatide) Now Available Through Ro Body Program Lilly plans $200M expansion in China to make tirzepatide meds Savings & Resources Mounjaro (tirzepatide) Oral Tirzepatide TrimRx
Quick Dispatch:
Your tirzepatide in chinese Eli Lilly's Mounjaro added to China's state insurance list for diabetes treatment orders ship within 1-2 business days.
Delivery Options:
- Standard: 3-7 business days
- Fast: 2-3 business days
- Express: 1-2 business days
Order Tracking:
You'll receive a tracking link by email once your tirzepatide in chinese Eli Lilly's Mounjaro added to China's state insurance list for diabetes treatment ships.
Need Help?
Questions about tirzepatide in chinese Eli Lilly's Mounjaro added to China's state insurance list for diabetes treatment, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide in chinese Eli Lilly's Mounjaro added to China's state insurance list for diabetes treatment in your area.
Get Shipping Estimates
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
Lilly's Weight-Loss Drug Approved in China Amid Race With Novo
26.72
Media Centre
26.54
💊 OEM Tirzepatide Injection from Chinese Manufacturer! Multiple strengths: 2.5mg-15mg. Long expiry (2028). Pre-filled pen, bulk supply. Competitive factory pricing. Ideal for Southeast Asian distributors & pharmacies. Custom OEM packaging available. 📩
27.08
MOUNJARO-RLDs & Medicines' Supply-Guangzhou TOSUN Pharmaceutical Co., Ltd
24.71
Eli Lilly's Famed Weight Loss Drug Zepbound Scores Chinese Approval
20.64
Tirzepatide Sheds Pounds in Chinese Adults With BMI as Low as 24
27.17
Tirzepatide, the "Drug King", Sees 70% Price Cut, Transforming Blood Sugar Control and Weight Loss Markets
25.37
4.2 ★★★★★
Based on 294 reviews
Sort
Product Reviews
★★★★★ 5
Buena compra !!
Color: Black-satin, Size: Medium
Me gustó el detalle y la caída del pantalón, lo compraré otra vez en el futuro.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 3, 2025
★★★★★ 1
Runs EXTREMELY small
Color: Black-satin, Size: 3X-Large
Ordered a 3X but got a XS…i am a 42-44, got the 3X to have tapered to my fit, but upon opening the pants, it seemed they may be more of a 32-34 and the adjustable straps aren’t really adjustable, they are just buckles sewed in place for design. The 3X tag sewn in is a complete lie! Only giving 1 star because they did have the satin tuxedo stripe on the side!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on November 26, 2025
★★★★★ 1
too long for them to come in it's not worth the headache not true
Color: Black-satin, Size: X-Large
I waited forever and when it finally came it was too small, they run small not true size
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 16, 2026
★★★★★ 2
Too small
Color: Black-satin, Size: X-Large
Nice material but far too small compared to the size that it says.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 11, 2026
recommand products
FDA has announced that the shortage of #tirzepatide, the ingredient in Lilly's Mounjaro and Zepbound, has been resolved. Compounding #pharmacies are required to cease production of compounded versions of tirzepatide within the
20.19
US judge denies injunction, restricting copies of Lilly weight-loss drug
20.47
Eli Lilly sues companies selling alternative versions of its weight loss drug
21.08
New Tirzepatide Access and Pricing Through Self-Pay Options
24.06
FDA Says Compounded Tirzepatide Must Exit the Market
22.10